← back to search

Jie Hu

Chengdu Medical College · CN
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Genomic variations and chromosomal abnormalities, Epilepsy research and treatment, Glioma Diagnosis and Treatment, and Lung Cancer Treatments and Mutations.
h-index
30
citations
3,162
works
151
NIH funding
primary concept
Medicine
email

Recent publications

C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderly
Clinical Nutrition ESPEN 2024cited by 40position: middledoi
IL21 inhibits miR-361-5p to promote MAP3K9 and further aggravate the progression of shoulder arthritis
Aging 2024cited by 2position: middledoi
Current status of PD-(L)1 inhibitor usage in advanced or metastatic non-small cell lung cancer: A national survey of oncologists in China.
Journal of Clinical Oncology 2024cited by 0position: middledoi
Ultrasound identification of hepatic echinococcosis using a deep convolutional neural network model in China: a retrospective, large-scale, multicentre, diagnostic accuracy study
The Lancet Digital Health 2023cited by 30position: middledoi
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease
Translational Lung Cancer Research 2023cited by 27position: middledoi
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies
BMC Medicine 2023cited by 21position: middledoi
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Journal of Clinical Oncology 2022cited by 271position: middledoi
Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery
Therapeutic Advances in Neurological Disorders 2022cited by 10position: middledoi
Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease
Annals of Palliative Medicine 2022cited by 10position: middledoi
ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma
Disease Markers 2022cited by 7position: middledoi
Reproductive outcomes in individuals with chromosomal reciprocal translocations
Genetics in Medicine 2021cited by 52position: middledoi
Strigolactones and Brassinosteroids Antagonistically Regulate the Stability of the D53–OsBZR1 Complex to Determine FC1 Expression in Rice Tillering
Molecular Plant 2019cited by 213position: middledoi
BES1 Functions as the Co-regulator of D53-like SMXLs to Inhibit BRC1 Expression in Strigolactone-Regulated Shoot Branching in Arabidopsis
Plant Communications 2019cited by 73position: firstdoi
Targeted exome sequencing reveals novel USH2A mutations in Chinese patients with simplex Usher syndrome
BMC Medical Genetics 2015cited by 11position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Xuelu Wang · Fudan University2 papers (2019–2019)Shiyong Sun · Fudan University2 papers (2019–2019)Yuanyuan Ji · Fudan University2 papers (2019–2019) · 1 papers (2015–2015)Yun Fan · Harbin Medical University1 papers (2024–2024)Jiangyong Wang · Shantou University1 papers (2024–2024)Yinuo Pan · Shihezi University1 papers (2015–2015)Yang Yang · Harbin Medical University1 papers (2022–2022)Xinghua Cheng · National University of Defense Technology1 papers (2022–2022) · 1 papers (2021–2021)Wei Hu · Shihezi University1 papers (2024–2024)Chunxia Su · Tongji University1 papers (2024–2024)Huai Bi · Nantong University1 papers (2015–2015) · 1 papers (2021–2021)Kangning Hao · Hebei Medical University1 papers (2024–2024) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2015–2015) · 1 papers (2021–2021)Xiaohua Liang · Guangdong Pharmaceutical University1 papers (2022–2022)